DEADLINE ALERT for JYD, STUB, ARE, and SFM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

(NASDAQ:JYD),(NASDAQ:SFM),(NYSE:ARE),(NYSE:STUB), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged […]

DEADLINE ALERT for JYD, STUB, ARE, and SFM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for JYD, STUB, ARE, and SFM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

(NYSE:FUN),(NYSE:INSP),(NASDAQ:TLX), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders

Tiger BioSciences Spotlights Major Clinical and Scientific Milestones Following Significant 2025 Research Investment

Tiger BioSciences highlights a series of major clinical and scientific achievements resulting from the company's expanded investment in evidence‑based research throughout 2025. This strategic focus has strengthened Tiger BioSciences' position as a market leader heading into 2026, with a portfolio increasingly defined by data, clinical validation, and scientific evidence. https://mma.prnewswire.com/media/2823019/TigerBiosciencesCircleColor_copy_Logo.jpg In 2025, Tiger BioSciences supported

Cemtrex, Inc. Announces $2 Million Registered Direct Offering

(NASDAQ:CETX),(Pinksheets:CETXP),(PinkSheets:CETXP),(NASDAQ:CETXW), Hauppauge, NY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Cemtrex, Inc. (NASDAQ: CETX) (the “Company”), an advanced security technology and industrial services company, today announced that it has entered into a definitive agreement for the purchase of approximately 888,889 shares and / or pre funded warrants with a single institutional investor, at a purchase price

Naoris Protocol Caps Breakout Year of Market Validation and Prepares for Upcoming Mainnet Launch

Miami, FL / Porto, Portugal , Dec. 30, 2025 (GLOBE NEWSWIRE) — Naoris Protocol, the world's first decentralized cybersecurity mesh powered by a post-quantum blockchain and distributed AI, is gearing up for its highly anticipated Mainnet launch, following a banner year of growth in 2025. 2025 marked a decisive shift in how governments, enterprises, and

Divexa Exchange Releases Annual Compliance and Risk Governance Whitepaper Highlighting 2025 Regulatory Progress

New York, NY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Divexa Exchange has released its Annual Compliance and Risk Governance Whitepaper, providing a comprehensive overview of the platform's governance structure, risk-management architecture, and regulatory alignment efforts across global jurisdictions. The publication reflects Divexa Exchange's ongoing commitment to transparency, operational discipline, and institution-ready standards in the evolving

Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

(NYSE:INSP), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock

Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

(NYSE:FCX), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15,

Scroll to Top